Abstract:The objective of the present study was to develop once-daily sustained-release matrix tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases. The tablets were prepared by the wet granulation method. Ethanolic solutions of ethylcellulose (EC), Eudragit RL-100, Eudragit RS-100, and polyvinylpyrrolidone were used as granulating agents along with hydrophilic matrix materials like hydroxypropyl methylcellulose (HPMC), sodium carboxymethylcellulose, and sodium alginate. The granules were evaluated for angle of repose, bulk density, compressibility index, total porosity, and drug content. The tablets were subjected to thickness, diameter, weight variation test, drug content, hardness, friability, and in vitro release studies. The granules showed satisfactory flow properties, compressibility, and drug content. All the tablet formulations showed acceptable pharmacotechnical properties and complied with in-house specifications for tested parameters. According to the theoretical release profile calculation, a once-daily sustained-release formulation should release 5.92 mg of nicorandil in 1 hour, like conventional tablets, and 3.21 mg per hour up to 24 hours. The results of dissolution studies indicated that formulation F-I (drug-to-HPMC, 1:4; ethanol as granulating agent) could extend the drug release up to 24 hours. In the further formulation development process, F-IX (drug-to-HPMC, 1:4; EC 4% wt/vol as granulating agent), the most successful formulation of the study, exhibited satisfactory drug release in the initial hours, and the total release pattern was very close to the theoretical release profile. All the formulations (except F-IX) exhibited diffusion-dominated drug release. The mechanism of drug release from F-IX was diffusion coupled with erosion.

STUDIES ON NICARDIPINE HYDROCHLORIDE TIMED-RELEASE TABLETS

Study on Pharmacokinetics and Bioavailability of Nimodipine Nanostructured Lipid Carrier in Rats

In vitro and in vivo studies on pulsatile release ta blets of diltiazem hydrochloride of the erosion-dispersion type

Studies on the pharmacokinetics and relative bioavailability of nimodipine sustained release capsules in volunteers

Studies on in Vivo and in Vitro Dissolution of Nitrendipine Delayed Release Tablets

Evaluation in vitro and in vivo of nifedipine controlled-release tablets

[Studies on Pulsatile Release Tablets of Diltiazem Hydrochloride in Explosion Way].

In Vivo Evaluation of Two Novel Controlled-Release Nitrendipine Formulations

Preparation of Nitrendipine Pulsatile Capsules Controlled by Erodible Plugs

Preparation Technique and Dissolution Rate of Nifedipine Sustained-release Hydrogels

Preparation of Nitrendipine Sustained Release Tablets and Its Release in Vitro

Preparation and in Vitro Release of Nifedipine Delayed-Onset Sustained-Release Tablets

Release Kinetics and in Vitro-in Vivo Correlation of Nimodipine Sustained-release Soft Gelatin Capsule

Relative bioavailability and pharmacokineties of two oral nifedipine sustained-release capsules in Chinese volunteers after single dose administration

Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation

Kinetic study and in vitro drug release studies of nitrendipine loaded arylamide grafted chitosan blend microspheres

Modulating the nifedipine release from sustained release matrix tablets using hydrophilic polymers

Research of Extended Release Nifedipine Tablets(I) release rate

Preparation and in vitro evaluation of nifedipine controlled-release coated pellets

A transdermal microemulsion-based hydrogel of nisoldipine: Preparation, in vitro characterization and in vivo pharmacokinetic evaluation

Study on the preparation of carboxymethyl chitosan-coated nimodipine nanoliposomes and their in vitro release